MCT1-Pyruvate-H3K27ac Axis: A Metabolic-Epigenetic Circuit Governing B Cell Class Switch Recombination

H3K27ac: The Epigenetic Bridge Linking Cellular Metabolism to B Cell Transcriptional Programs

Histone H3 lysine 27 acetylation (H3K27ac) marks transcriptionally permissive enhancer regions by neutralizing positively charged histone tails to relax chromatin compaction. Acetyl-CoA derived from glycolytic metabolites serves as the primary substrate for histone acetyltransferases, creating a direct biochemical connection between nutrient availability and immune gene expression. Activated B cells undergo dramatic glycolytic rewiring upon antigen stimulation to support proliferation and antibody diversification, yet the metabolic intermediate controlling enhancer acetylation remained poorly characterized before landmark work from Tsinghua University’s Chen Ligong and Liu Wanli teams. Their research establishes the MCT1-pyruvate-H3K27ac-AID signaling cascade as a core regulatory module governing immunoglobulin class switch recombination (CSR) for humoral immunity basic research.

MCT1 as an Underexplored Regulator of Activated B Cell Glycolytic Flux

Monocarboxylate transporter 1 (MCT1) mediates bidirectional transmembrane transport of pyruvate and lactate to sustain glycolysis or oxidative phosphorylation cycles within leukocytes. Robust MCT1 transcriptional upregulation occurs following B cell antigen crosslinking, but its functional contribution to antibody production and CSR lacked systematic in vivo validation. Mature germinal center B cells rely on accelerated glycolysis to generate biomass and epigenetic cofactors, generating an unmet experimental need to dissect how monocarboxylate pools shape immunoglobulin gene transcription. Genetic knockout and small-molecule MCT inhibitor models provide controllable assay systems to isolate pyruvate-dependent epigenetic remodeling events in primary lymphocyte cultures.

Genetic Ablation of MCT1 Induces Severe CSR Defects In Vivo and Ex Vivo

B cell-specific Mb1-Cre Mct1 conditional knockout murine strains serve as core genetic tools to define MCT1’s non-redundant immune functions. Basal B cell developmental progression and circulating IgM concentrations remain comparable between knockout and wild-type littermates, confirming MCT1 is dispensable for early lymphopoiesis and constitutive innate antibody secretion. After NP-KLH immunization, knockout cohorts display drastically reduced antigen-specific IgG titers alongside contracted germinal center compartments and diminished IgG1+ B cell frequencies. Ex vivo LPS/IL-4 stimulation recapitulates this CSR suppression phenotype, while CHC-mediated MCT pharmacological inhibition replicates identical differentiation defects, verifying transporter activity as a mandatory prerequisite for efficient IgG isotype switching.

MCT1 Loss Triggers Global Glycolysis-to-OxPhos Metabolic Reprogramming

U-¹³C isotopic glucose tracing quantifies comprehensive metabolic shifts triggered by MCT1 deletion in activated B cell populations. Glycolytic throughput declines sharply with impaired HK2 transcriptional induction, while tricarboxylic acid intermediates citrate, succinate and malate accumulate within cytoplasmic compartments. Mitochondrial fusion morphology and elevated basal oxygen consumption mark a metabolic shift toward oxidative phosphorylation. Contrary to initial hypotheses, MCT1 ablation does not drive intracellular lactate buildup; the dominant metabolic perturbation is consistent intra- and extracellular pyruvate depletion, which acts as the primary signaling intermediate linking monocarboxylate transport to downstream epigenetic modification cascades.

Pyruvate Regulates AID Transcription via Genome-Wide H3K27 Acetylation Dynamics

Activation-induced cytidine deaminase (AID), encoded by the Aicda locus, acts as the rate-limiting enzyme for CSR, and its transcript abundance is markedly suppressed in MCT1-deficient B lymphocytes. Exogenous pyruvate supplementation fails to rescue AID expression in knockout isolates due to impaired transmembrane uptake, while cell-permeable methyl pyruvate fully restores AID levels and IgG1 conversion efficiency. Combined ATAC-seq and H3K27ac ChIP-seq datasets document reduced chromatin accessibility and diminished acetylation peaks across the Aicda promoter and distal enhancer regions in Mct1-/- cells. Mechanistic profiling reveals disrupted equilibrium between acetyltransferase CBP and deacetylases HDAC2/SIRT1 upon pyruvate scarcity; selective SIRT1 inhibitor incubation partially recovers H3K27ac deposition and CSR capacity. Carbon isotope labeling further confirms pyruvate-derived carbon skeletons directly incorporate into H3K27 acetyl moieties in primary B cell nuclei.

MCT1 Upregulation Correlates with Pathogenic Autoantibody Responses in SLE Preclinical Models

Translational preclinical profiling extends the MCT1-pyruvate-H3K27ac axis to autoimmune disorder mechanism research. Peripheral mononuclear cells isolated from systemic lupus erythematosus experimental subjects carry significantly elevated MCT1 transcript and protein levels relative to healthy control cohorts. Mct1 genetic knockout mitigates hallmark SLE pathological phenotypes in murine models, including splenomegaly, contracted germinal center compartments, reduced IgG1+ B cell populations and diminished renal anti-dsDNA antibody deposition. In vitro dexamethasone incubation suppresses MCT expression, while in vivo CHC MCT inhibitor administration lowers circulating pathogenic IgG titers, establishing MCT1 as a tractable molecular target for autoimmune therapeutic screening pipelines.

Epigenetic Detection Reagents from ANT BIO PTE. LTD. for Metabolic-Immune Research

Dissecting the MCT1-H3K27ac-AID regulatory cascade demands high-specificity detection tools for histone acetylation and global acetylome profiling workflows. ANT BIO PTE. LTD. supplies two fully validated core reagents optimized for ChIP-seq, Western blot, IHC and immunoprecipitation assays across murine and human immune cell matrices. S0B0546 Histone H3 (acetyl K27) Recombinant Rabbit mAb (Clone S-699-50) delivers exclusive epitope recognition without cross-reactivity against other lysine acetylation marks. S0F0004 anti-acetyllysine agarose affinity beads enable unbiased pulldown of all acetylated cellular peptides for quantitative LC-MS/MS acetylome comparative profiling across wild-type and MCT1 knockout B cell cohorts. Every reagent batch undergoes peptide competition and knockout cell line validation to eliminate non-specific background signals during multi-omics metabolic epigenetic screening campaigns.

Fundamental Experimental Workflows Utilizing ANT BIO PTE. LTD. Acetylation Reagents

ChIP-seq profiling with S0B0546 antibody maps locus-specific H3K27ac depletion at the Aicda enhancer region in MCT1-deficient B cell populations. Time-course Western blot analysis quantifies global H3K27ac dynamic shifts after methyl pyruvate or SIRT inhibitor compound stimulation cycles. Multiplex FFPE murine spleen tissue IHC co-stains H3K27ac with B220 germinal center markers to visualize epigenetic gradient differences across lymphoid microdomains. Anti-acetyllysine agarose bead immunoprecipitation enriches acetylated protein fractions for mass spectrometry identification of metabolism-dependent histone and non-histone acetylation substrates. Intracellular flow cytometry protocols enable single-cell H3K27ac quantification in sorted IgM+ and IgG1+ primary B cell subpopulations for epigenetic phenotype stratification.

ANT BIO PTE. LTD. Histone Acetylation Detection Reagent Portfolio

ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs
At ANT BIO PTE. LTD., we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.

Disclaimer
This article was partially created with the assistance of artificial intelligence. If any content involves copyright or intellectual property issues, please inform us, and we promise to verify and remove it immediately.